Knockdown of human serine/threonine kinase 33 suppresses human small cell lung carcinoma by blocking RPS6/BAD signaling transduction.

Abstract

Small cell lung cancer (SCLC) is characterized by rapid growth rate and a tendency to metastasize to distinct sites of patients' bodies. The human serine/threonine kinase 33 (STK33) gene has shown its potency as a therapeutic target for prevention of lung carcinomas including non-small cell lung cancer (NSCLC), but its function in the oncogenesis and development of SCLC remains unrevealed. In the current study, it was hypothesized that STK33 played a key role in the proliferation, survival, and invasion of SCLC cells. The expression of STK33 in human SCLC cell lines NCI-H466 and DMS153 was inhibited by specific shRNA. The cell proliferation, cell apoptosis, and cell invasion of the cells were assessed with a series of in vitro assays. To explore the mechanism through which STK33 gene exerted its function in the carcinogenesis of SCLC cells, the effect of STK33 knockdown on the activity of S6K1/RPS6/BAD signaling was detected. Then the results were further confirmed with STK33 inhibitor ML281 and in vivo assays. The results demonstrated that inhibition of STK33 in SCLC cells suppressed the cell proliferation and invasion while induced cell apoptosis. Associated with the change in the phenotypic features, knockdown of STK33 also decreased the phosphorylation of RPS6 and BAD while increased the expression of cleaved caspase 9, indicating that apoptosis induced by STK33 suppression was mediated via mitochondrial pathway. Similar to the results of STK33 knockdown, incubating NCI-H466 cells with STK33 inhibitor also reduced the cell viability by suppressing RPS6/BAD pathways. Additionally, STK33 knockdown also inhibited tumor growth and RPS6/BAD activity in mice models. Findings outlined in our study were different from that in NSCLC to some extent: knockdown of STK33 in SCLC cells induced the apoptosis through mitochondrial pathway but independent of S6K1 function, inferring that the function of STK33 might be cancer type specific.

• Authors: E L Sun, C X Liu, Z X Ma, X Y Mou, X A Mu, Y H Ni, X L Li, D Zhang, Y R Ju
• Journal: Neoplasma (Neoplasma) 2017 Vol. 64 Issue 6 Pg. 869-879 ISSN: 0028-2685 [Print] Slovakia
• PMID: 28895411 (Publication Type: Journal Article)

Chemical References

• BAD protein, human
• Ribosomal Protein S6
• bcl-Associated Death Protein
• Protein Serine-Threonine Kinases
• STK33 protein, human

Topics

• Animals
• Apoptosis
• Cell Line, Tumor
• Cell Proliferation
• Gene Knockdown Techniques
• Humans
• Lung Neoplasms (drug therapy, pathology)
• Mice
• Protein Serine-Threonine Kinases (genetics)
• Ribosomal Protein S6 (genetics)
• Signal Transduction
• Small Cell Lung Carcinoma (drug therapy, pathology)
• bcl-Associated Death Protein (genetics)